![Craig Greathouse](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Craig Greathouse
Verwaltungsdirektor bei MVB FINANCIAL CORP.
Vermögen: 403 706 $ am 31.05.2024
Aktive Positionen von Craig Greathouse
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
MVB FINANCIAL CORP. | Verwaltungsdirektor | 27.01.2022 | - |
Personalreferent | 10.05.2018 | 27.01.2022 |
Karriereverlauf von Craig Greathouse
Ehemalige bekannte Positionen von Craig Greathouse
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Mylan, Inc.
![]() Mylan, Inc. Pharmaceuticals: MajorHealth Technology Mylan, Inc. develops, manufactures, and licenses generic pharmaceuticals. The firm operates its business through two segments: Generics and Specialty. The Generics segment primarily develops, manufactures, sells and distributes generic or branded generic pharmaceutical products in tablet, capsule, injectable or transdermal patch form, as well as API. The Specialty segment engages mainly in the development, manufacture and sale of branded specialty nebulized and injectable products. The company was founded by Milan Puskar and Don Panoz in 1961 and is headquartered in Canonsburg, PA. | Personalreferent | 01.01.2010 | 01.01.2018 |
United Way of Monongalia & Preston Counties | Direktor/Vorstandsmitglied | - | - |
Corporate Officer/Principal | - | - |
Ausbildung von Craig Greathouse
West Virginia University | Undergraduate Degree |
University of South Carolina | Graduate Degree |
Statistik
International
Vereinigte Staaten | 6 |
Operativ
Human Resources Officer | 2 |
Chief Administrative Officer | 1 |
Undergraduate Degree | 1 |
Sektoral
Consumer Services | 3 |
Finance | 2 |
Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
MVB FINANCIAL CORP. | Finance |
Private Unternehmen | 2 |
---|---|
United Way of Monongalia & Preston Counties | |
Mylan, Inc.
![]() Mylan, Inc. Pharmaceuticals: MajorHealth Technology Mylan, Inc. develops, manufactures, and licenses generic pharmaceuticals. The firm operates its business through two segments: Generics and Specialty. The Generics segment primarily develops, manufactures, sells and distributes generic or branded generic pharmaceutical products in tablet, capsule, injectable or transdermal patch form, as well as API. The Specialty segment engages mainly in the development, manufacture and sale of branded specialty nebulized and injectable products. The company was founded by Milan Puskar and Don Panoz in 1961 and is headquartered in Canonsburg, PA. | Health Technology |
- Börse
- Insiders
- Craig Greathouse
- Erfahrung